Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)
Clinical trial NCT01135992 · COMPLETED
Trial details
- NCT number
- NCT01135992
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2010-11-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.